William T. Senapedis, Ph.D.

Affiliations: 
2011 Harvard University, Cambridge, MA, United States 
Area:
Intracellular Compartmentation
Google:
"William Senapedis"

Parents

Sign in to add mentor
Pamela A. Silver grad student 2011 Harvard
 (Forkhead at the Crossroads of Cancer and Healthy Lifespan.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Li N, Lopez MA, Linares M, et al. (2018) Dual PAK4-NAMPT inhibition impacts growth and survival, and increases sensitivity to DNA-damaging agents in Waldenstrom Macroglobulinemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Kashyap T, Argueta C, Unger T, et al. (2018) Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents. Oncotarget. 9: 30773-30786
Gravina GL, Senapedis W, McCauley D, et al. (2014) Nucleo-cytoplasmic transport as a therapeutic target of cancer. Journal of Hematology & Oncology. 7: 85
Senapedis WT, Kennedy CJ, Boyle PM, et al. (2011) Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chain. Molecular Biology of the Cell. 22: 1791-805
Aldaye FA, Senapedis WT, Silver PA, et al. (2010) A structurally tunable DNA-based extracellular matrix. Journal of the American Chemical Society. 132: 14727-9
Gómez-Baldó L, Schmidt S, Maxwell CA, et al. (2010) TACC3-TSC2 maintains nuclear envelope structure and controls cell division. Cell Cycle (Georgetown, Tex.). 9: 1143-55
Astrinidis A, Senapedis W, Henske EP. (2006) Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner Human Molecular Genetics. 15: 287-297
Astrinidis A, Senapedis W, Coleman TR, et al. (2003) Cell Cycle-regulated Phosphorylation of Hamartin, the Product of the Tuberous Sclerosis Complex 1 Gene, by Cyclin-dependent Kinase 1/Cyclin B Journal of Biological Chemistry. 278: 51372-51379
Khare L, Astrinidis A, Senapedis W, et al. (2002) Expression of wild type and mutant TSC2, but not TSC1, causes an increase in the G1 fraction of the cell cycle in HEK293 cells Journal of Medical Genetics. 39: 676-680
See more...